| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000268015.1 |
Nilotinib |
Brain lower grade glioma |
0.038294025 |
Resistant |
| ENSG00000268015.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.010458296 |
Resistant |
| ENSG00000268015.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.046021607 |
Sensitive |
| ENSG00000268015.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006708464 |
Sensitive |
